Successful treatment of invasive pulmonary aspergillosis in an immunocompetent host

Respirology

Volumn 10, Issue 3, 2005, Pages 393-395

  Polat, Gülru ^a   Ürpek, Gülcan ^a   Yilmaz, Ufuk ^a,b   Büyükşirin, Melih ^a   Karadaǧ Polat, Serpil ^a   Uluer, Servet ^a   Tibet, Gültekin ^a  

^a Izmir Chest Diseases and Surgery Training Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Immunocompetent host; Invasive aspergillosis; Pneumonia

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CEFTRIAXONE; CLARITHROMYCIN; LEVOFLOXACIN;

ADULT; ARTICLE; ASPERGILLUS FUMIGATUS; ASPIRATION BIOPSY; CASE REPORT; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GRAM STAINING; HUMAN; IMMUNOCOMPETENCE; LUNG ASPERGILLOSIS; PRIORITY JOURNAL; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; LIPOSOMES; MIDDLE AGED; RADIOGRAPHY, THORACIC; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 22644434266     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2005.00690.x     Document Type: Article

References (14)

1. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann. Intern. Med. 1984; 100: 345-51.
2. Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Invest. 1985; 76: 1755-64.
3. Minamoto GY, Barlam TF, Vander Els NJ. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 1992; 14: 66-74.
4. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin. Infect. Dis. 1994; 19 (Suppl. 1): S33-40.
5. Denning DW, Follansbee SE, Scolaro M, Norris S, Edelstein H, Stevens DA. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 1991; 324: 654-62.
6. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988-99.
7. Karam GH, Griffin FM Jr. Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts. Rev. Infect. Dis. 1986; 8: 357-63.
8. Levitz SM, Diamond RD. Changing patterns of aspergillosis infections. Adv. Intern. Med. 1984; 30: 153-74.
9. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114: 629-34.
10. Ali ZA, Ali AA, Tempest ME, Wiselka MJ. Invasive pulmonary aspergillosis complicating chronic obstructive pulmonary disease in an immunocompetent patient. J. Postgrad. Med. 2003; 49: 78-80.
11. Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. 13 Aspergillus Study Group. Medicine (Baltimore) 2000; 79: 250-60.
12. Denning DW, Lee JY, Hostetler JS et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am. J. Med. 1994; 97: 135-44.
13. Popp AI, White MH, Quadri T, Walshe L, Armstrong D. Amphotericin B with and without itraconazole for invasive aspergillosis: a three-year retrospective study. Int. J. Infect. Dis. 1999; 3: 157-60.
14. Denning DW. Invasive aspergillosis. Clin. Infect. Dis. 1998; 26: 781-805.